Insufficient scRNA-seq data for expression of CRYBB2 at single-cell level.
Insufficient scRNA-seq data for expression of CRYBB2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 99% | 40.26 | 649 / 653 | 30% | 0.60 | 183 / 605 |
brain | 88% | 31.02 | 2317 / 2642 | 41% | 0.92 | 289 / 705 |
prostate | 94% | 26.13 | 230 / 245 | 23% | 0.38 | 114 / 502 |
kidney | 85% | 14.45 | 76 / 89 | 18% | 0.30 | 160 / 901 |
lung | 84% | 13.62 | 483 / 578 | 14% | 0.27 | 156 / 1155 |
adrenal gland | 84% | 13.59 | 216 / 258 | 13% | 0.23 | 29 / 230 |
uterus | 69% | 8.06 | 118 / 170 | 20% | 0.50 | 92 / 459 |
blood vessel | 88% | 16.61 | 1181 / 1335 | 0% | 0 | 0 / 0 |
breast | 71% | 11.01 | 324 / 459 | 16% | 0.29 | 177 / 1118 |
ovary | 57% | 6.37 | 103 / 180 | 28% | 0.62 | 119 / 430 |
esophagus | 62% | 8.79 | 894 / 1445 | 23% | 0.37 | 42 / 183 |
bladder | 71% | 8.71 | 15 / 21 | 12% | 0.29 | 61 / 504 |
intestine | 67% | 10.50 | 646 / 966 | 14% | 0.28 | 72 / 527 |
skin | 69% | 12.26 | 1240 / 1809 | 3% | 0.08 | 16 / 472 |
muscle | 64% | 13.43 | 511 / 803 | 0% | 0 | 0 / 0 |
liver | 52% | 5.81 | 118 / 226 | 10% | 0.18 | 39 / 406 |
pancreas | 50% | 4.73 | 164 / 328 | 11% | 0.19 | 19 / 178 |
stomach | 50% | 5.11 | 180 / 359 | 8% | 0.11 | 22 / 286 |
spleen | 54% | 5.56 | 131 / 241 | 0% | 0 | 0 / 0 |
adipose | 51% | 5.58 | 613 / 1204 | 0% | 0 | 0 / 0 |
heart | 43% | 4.10 | 373 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.21 | 4 / 29 |
eye | 0% | 0 | 0 / 0 | 13% | 2.20 | 10 / 80 |
peripheral blood | 12% | 1.09 | 111 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.15 | 4 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002088 | Biological process | lens development in camera-type eye |
GO_0007601 | Biological process | visual perception |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0005212 | Molecular function | structural constituent of eye lens |
GO_0005198 | Molecular function | structural molecule activity |
Gene name | CRYBB2 |
Protein name | Beta-crystallin B2 (Beta-B2 crystallin) (Beta-crystallin Bp) |
Synonyms | CRYB2A CRYB2 |
Description | FUNCTION: Crystallins are the dominant structural components of the vertebrate eye lens. FUNCTION: Crystallins are the dominant structural components of the vertebrate eye lens. . FUNCTION: Crystallins are the dominant structural components of the vertebrate eye lens. . FUNCTION: Crystallins are the dominant structural components of the vertebrate eye lens. . FUNCTION: Crystallins are the dominant structural components of the vertebrate eye lens. . FUNCTION: Crystallins are the dominant structural components of the vertebrate eye lens. . |
Accessions | A0A0H3W5U0 A0A0H3W5Q8 ENST00000651629.1 P43320 A0A0H3W5H9 R4UMM2 A0A0H3W5J2 ENST00000398215.3 |